Mapping vision system development in embryos
Part of Brain & nervous system, Eyes & vision, Genetic & congenital clinical trials.
This trial studies embryos to understand how the visual system develops normally and abnormally. It compares tissues from embryos with developmental problems to healthy ones, aiming to create a detailed map of early vision system growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an embryo between 8 and 20 weeks of gestation (timing unclear from description).
- Either your development is abnormal (doctor confirms issue) and pregnancy is being ended, or you are normal (no eye or brain defects found).
- Your eye and brain tissues must be intact and usable for advanced lab tests.
- Your parent or guardian signed a consent form allowing your tissues to be used for research, without payment.
- Your tissues must not be too damaged by disease, handling, or storage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study looks at early vision (what babies can see and how their eyes respond) in children who have risk factors for future “cerebral visual impairment,” meaning vision problems caused by the brain. It may help doctors spot issues earlier and better understand which early visual signs matter.
This study looks at eye tissue from people with advanced diabetic retinopathy to understand why the disease gets so severe. It aims to find new ways to treat or prevent blindness in the future. You would be contributing tissue from a surgery you're already having.
This study uses pictures to map the tiny blood vessels in an infant’s retina (the back of the eye). It may help researchers better understand how eye blood vessel growth happens in premature babies who need screening for ROP (retinopathy of prematurity).
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This trial is testing a new software tool that helps doctors see and assess different parts of the retina in eye scans. It aims to see how well the tool works in people with and without certain retina conditions.
This study collects samples like blood and a small skin biopsy (and sometimes urine, hair, or saliva) to better understand causes of eye diseases. The goal is to study eye conditions and may help researchers build better tests or treatments.
Hear when a new Embryonic Development trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.